Pre-clinical investigation of STAT3 pathway in bladder cancer: Paving the way for clinical translation-Reference-Cited by-同舟云学术

Pre-clinical investigation of STAT3 pathway in bladder cancer: Paving the way for clinical translation

Published:2021-01 Issue: Volume:133 Page:111077
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Mirzaei Sepideh,Gholami Mohammad Hossein,Mahabady Mahmood Khaksary,Nabavi Noushin,Zabolian Amirhossein,Banihashemi Seyed Mohammad,Haddadi Amirabbas,Entezari Maliheh,Hushmandi Kiavash,Makvandi Pooyan,Samarghandian Saeed,Zarrabi Ali^ORCID,Ashrafizadeh Milad,Khan Haroon

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference254 articles.

1. STAT3 signaling in immunity;Hillmer;Cytokine Growth Factor Rev.,2016

2. Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130;Lutticken;Science,1994

3. Mammary gland factor activated by prolactin on mammary epithelial cells and acute-phase response factor activated by interleukin-6 in liver cells share DNA binding and transactivation potential;Standke;Mol. Endocrinol.,1994

4. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6;Zhong;Science,1994

5. The interleukin-6-activated acute-phase response factor is antigenically and functionally related to members of the signal transducer and activator of transcription (STAT) family;Wegenka;Mol. Cell. Biol.,1994

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stat3 Inhibitors TTI-101 and SH5-07 Suppress Bladder Cancer Cell Survival in 3D Tumor Models;Cells;2024-08-31

2. MicroRNA-98: the multifaceted regulator in human cancer progression and therapy;Cancer Cell International;2024-06-13

3. PCSK5 downregulation promotes the inhibitory effect of andrographolide on glioblastoma through regulating STAT3;Molecular and Cellular Biochemistry;2024-03-29

4. ITM2A inhibits the progression of bladder cancer by downregulating the phosphorylation of STAT3;American Journal of Cancer Research;2024

5. A review of Glycogen Synthase Kinase-3 (GSK3) inhibitors for cancers therapies;International Journal of Biological Macromolecules;2023-12